Stock Reports Archives | Psychedelic Spotlight

Math over Myth is your weekly guide to stocks and ETFs in the psychedelic sector, this week focusing on the ETF PSIL

Math over Myth is your weekly source for psychedelic stock updates, including Compass Pathways and Revive Therapeutics

Math over Myth is your weekly update on psychedelic stocks and ETFs, including ATAI, COMPASS, Cybin, GH Research, Mindset, Numinus, and more

Get the latest news on psychedelic stocks Cybin, Numinus, MindMed, ATAI, Mindset, Braxia, Tryp, Irwin Naturals, and Revive

Track the monthly performance of the psychedelic stock sector with our Math over Myth Stock News Roundup

Psychedelic stock MindMed enters free fall as news of a private equity offering of common stock spooks retail investors

The psychedelic corporate shakeout continues as another company, HAVN Life Sciences, folds due to lack of cash flow

In the latest installment of Math Over Myth we navigate psychedelic stock MindMed’s reverse split with Fibonacci numbers

If you want to invest in psychedelic stocks, ignore the hype and look at the technicals. We take a deep dive on atai Life Sciences & COMPASS Pathways

Cathie Wood is buying up stocks from the most dubious actors in the psychedelic sector. Given ARK Invest’s subpar performance, is that a good thing?